Cardiovascular complications in atypical haemolytic uraemic syndrome

Complement Genes Strongly Predict Recurrence and Graft Outcome in Adult Renal Transplant Recipients with Atypical Hemolytic and Uremic Syndrome

(2013) M. Le Quintrec et al.   AMERICAN JOURNAL OF TRANSPLANTATION

Combined Complement Gene Mutations in Atypical Hemolytic Uremic Syndrome Influence Clinical Phenotype

(2013) E. Bresin et al.   JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY

Recessive mutations in DGKE cause atypical hemolytic-uremic syndrome

(2013) Mathieu Lemaire et al.   NATURE GENETICS

Eculizumab in an anephric patient with atypical haemolytic uraemic syndrome and advanced vascular lesions

(2013) Z. D. Bekassy et al.   NEPHROLOGY DIALYSIS TRANSPLANTATION

Terminal Complement Inhibitor Eculizumab in Atypical Hemolytic–Uremic Syndrome

(2013) C.M. Legendre et al.   NEW ENGLAND JOURNAL OF MEDICINE

A novel hybrid CFHR1/CFH gene causes atypical hemolytic uremic syndrome

(2013) Stephen J. Eyler et al.   PEDIATRIC NEPHROLOGY

A systematic review of eculizumab for atypical haemolytic uraemic syndrome (aHUS)

(2013) John Rathbone et al.   BMJ Open

Treatment of Atypical Hemolytic Uremic Syndrome and Thrombotic Microangiopathies: A Focus on Eculizumab

(2012) Jan Schmidtko et al.   AMERICAN JOURNAL OF KIDNEY DISEASES

A prevalent C3 mutation in aHUS patients causes a direct C3 convertase gain of function

(2012) L. T. Roumenina et al.   BLOOD

Complement Factor H-Related Protein 1 Deficiency and Factor H Antibodies in Pediatric Patients with Atypical Hemolytic Uremic Syndrome

(2012) J. Hofer et al.   Clinical Journal of the American Society of Nephrology

The Role of the Host Defense System in the Development of Cerebral Vasospasm: Analogies between Atherosclerosis and Subarachnoid Hemorrhage

(2012) Hiroji Yanamoto et al.   EUROPEAN NEUROLOGY

STEC-HUS, atypical HUS and TTP are all diseases of complement activation

(2012) Marina Noris et al.   Nature Reviews Nephrology

Long-term eculizumab improves clinical outcomes in atypical hemolytic uremic syndrome

(2012) Ramon Vilalta et al.   PEDIATRIC NEPHROLOGY

Peripheral Gangrene in Children With Atypical Hemolytic Uremic Syndrome

(2012) M. Malina et al.   PEDIATRICS

Inflammation as a Marker for the Prediction of Internal Carotid Artery Restenosis Following Eversion Endarterectomy—Evidence From Clinical Studies

(2011) Slobodan Tanaskovic et al.   ANGIOLOGY

A novel hybrid CFH/CFHR3 gene generated by a microhomology-mediated deletion in familial atypical hemolytic uremic syndrome

(2011) N. J. Francis et al.   BLOOD

Regulation and Functions of Diacylglycerol Kinases

(2011) Yulia V. Shulga et al.   CHEMICAL REVIEWS

Inhibiting the C5–C5a receptor axis

(2011) Trent M. Woodruff et al.   MOLECULAR IMMUNOLOGY

Atherosclerosis: current pathogenesis and therapeutic options

(2011) Christian Weber et al.   NATURE MEDICINE

Relative Role of Genetic Complement Abnormalities in Sporadic and Familial aHUS and Their Impact on Clinical Phenotype

(2010) M. Noris et al.   Clinical Journal of the American Society of Nephrology

Mutations in alternative pathway complement proteins in American patients with atypical hemolytic uremic syndrome

(2010) Tara K. Maga et al.   HUMAN MUTATION

Clinical Features of Anti-Factor H Autoantibody-Associated Hemolytic Uremic Syndrome

(2010) M.-A. Dragon-Durey et al.   JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY

Complement: a key system for immune surveillance and homeostasis

(2010) Daniel Ricklin et al.   NATURE IMMUNOLOGY

Non-atheromatous arterial stenoses in atypical haemolytic uraemic syndrome associated with complement dysregulation

(2010) C. Loirat et al.   NEPHROLOGY DIALYSIS TRANSPLANTATION

Myocardial infarction is a complication of factor H-associated atypical HUS

(2010) M. Sallee et al.   NEPHROLOGY DIALYSIS TRANSPLANTATION

Maintenance of Kidney Function Following Treatment With Eculizumab and Discontinuation of Plasma Exchange After a Third Kidney Transplant for Atypical Hemolytic Uremic Syndrome Associated With a CFH Mutation

(2009) Jean-Claude Davin et al.   AMERICAN JOURNAL OF KIDNEY DISEASES

Characterization of complement factor H-related (CFHR) proteins in plasma reveals novel genetic variations of CFHR1 associated with atypical hemolytic uremic syndrome

(2009) C. Abarrategui-Garrido et al.   BLOOD

The role of the anaphylatoxins in health and disease

(2009) Andreas Klos et al.   MOLECULAR IMMUNOLOGY

Cardiovascular disease in children with CKD or ESRD

(2009) Marc R. Lilien et al.   Nature Reviews Nephrology

Thrombomodulin Mutations in Atypical Hemolytic–Uremic Syndrome

(2009) Mieke Delvaeye et al.   NEW ENGLAND JOURNAL OF MEDICINE

Atypical Hemolytic–Uremic Syndrome

(2009) Marina Noris et al.   NEW ENGLAND JOURNAL OF MEDICINE

Proximal Cerebral Artery Stenosis in a Patient with Hemolytic Uremic Syndrome: Fig 1.

(2008) M.D.I. Vergouwen et al.   AMERICAN JOURNAL OF NEURORADIOLOGY

Mutations in complement C3 predispose to development of atypical hemolytic uremic syndrome

(2008) V. Fremeaux-Bacchi et al.   BLOOD

The role of complement in atherosclerosis

(2008) Dorian O Haskard et al.   CURRENT OPINION IN LIPIDOLOGY

Myocardial infarction in thrombotic thrombocytopenic purpura: a single-center experience and literature review

(2008) Ali S. Wahla et al.   EUROPEAN JOURNAL OF HAEMATOLOGY

Myocardial necrosis in patients with thrombotic thrombocytopenic purpura: pathophysiology and rationale for specific therapy

(2008) David C. Sane et al.   EUROPEAN JOURNAL OF HAEMATOLOGY

Complement and the atypical hemolytic uremic syndrome in children

(2008) Chantal Loirat et al.   PEDIATRIC NEPHROLOGY

Characterization of mutations in complement factor I (CFI) associated with hemolytic uremic syndrome

(2007) David Kavanagh et al.   MOLECULAR IMMUNOLOGY